Former Gilead exec who oversaw $20B in drug sales joins C-suite of Boston pharma giant

A Gilead Sciences executive who left the San Fransisco pharmaceutical giant last month after nearly four years, has been ...

Former Gilead exec who oversaw $20B in drug sales takes global role at autoimmune disease company

Choose San Francisco Business Times as a preferred news source to see more of our reporting on Google. "I believe we rarely ...
The Caledonian-Record

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing ...

Oak Hill Bio and their partner are developing OHB-607, a recombinant human IGF-1/IGFBP-3 for the prevention of bronchopulmonary dysplasia in premature infants. Additional Oak Hill Bio assets that have ...

Ole Miss defense looks to redeem a humiliating showing against Georgia in the Sugar Bowl

Redemption will be on the minds of Mississippi Rebels defensive players when they meet third-ranked Georgia at Thursday’s ...